Peripheral uptake of triglyceride from plasma was investigated by intravenous fat tolerance tests and by postheparin lipoprotein lipase measurements in children with different types of glycogen storage disease.
Introduction
Little is known about the causes of hyperlipidemia in patients with glycogen storage disease (GSD) [4, 5, 81 .
The highest lipid levels are found in patients with a glucose 6-phosphatase deficiency. They have the highest fatty acid cholesterol ratios and sometimes even a pre-p-band on the electropheretograms. De novo fatty acid synthetizing activity from citrate is high in liver biopsies of these patients 171. The pathogenesis of the hypertriglyceridemia in patients with a glucose 6-phosphatase deficiency is presumed to be as follows: in the fasting state, conversion of glucose 6-phosphate to glucose is blocked, so that glycogen can only be degraded to pyruvate through the glycolytic pathway. Part of the excess pyruvate is converted into lactate, another part into acetyl-CoA, and thence into fatty acids, predominantly palmitate [4, 121. Hyperlipidemia is less striking in children with a deficiency of debranching enzyme or of the phosphorylase system. In the latter deficiencies, the hyperlipidemia is characterized by a dense p-lipoprotein band, no pre-p-lipoprotein band being present on the elec-tropheretograms; the glycolysis is enhanced postprandially, which leads to an increased lactate production and an increased liponeogenesis [4] .
Although enhanced lipid production in the liver probably plays a causative role in the pathogenesis of GSD hyperlipidemia, it may not be the only factor. A pathologically low triglyceride clearance rate might also be an important factor. By measuring the triglyceride elimination rate and the serum postheparin lipoprotein lipase activity, we tried to gain more insight into the apparently complex causes of the hyperlipidemia.
Materials and Methods

40
-min blood samples in most GSD patients, but in 5-min blood samples only i n most control subjects. As we concur with Rossner et al. [13] that the 5-min postheparin LPL activity probably gives more information about fat elimination than the 40-min value, we have chosen the 5-min value as representative of LPL activity. T h e LPL activity was determined by the method of Kelly [ l l ] as modified by Jansen and Hiilsmann [9] . T h e following minor modifications were introduced: the incubation mixture consisted of 1.1 ml Intralipid emulsion containing approximately 3.5 &i (14C)trioleate, 3.0 ml human plasma freed of p-lipoproteins as described by Jansen and Hiilsmann [9] , 6.0 ml 10% solution of bovine albumin in 0.2 M Tris buffer p H 8.5, and 1.9 ml 0.2 Tris buffer, p H 8.5. This The study seven patients with a glucose 6-mixture was kept at 37' for 40 min. After this pretreatphosphatase seven patients with a dement, 0.8 ml incubation medium was mixed with 0.2 branching enzyme and six patients with a ml plasma to be investigated. T h e incubation time was deficiency of the phosphorylase system. Enzymatic 35 min. studies had confirmed the diagnosis i n all patients (Tables 1-111) . T e n patients without hyperlipidemia in whom an intravenous fat tolerance test had been performed served as control subjects (Table IV) . They all had a normal nutritional status. Informed consent was obtained in each case.
An intravenous fat tolerance test was performed in all GSD patients and control subjects. Heparin-released plasma lipoprotein lipase (LPL) activity was measured in most GSD patients and in some control subjects. Both tests were performed on consecutive days. T h e patients and the control subjects did not fast before the tests in order to prevent hypoglycemia in the patients. T h e meals during the 12-hr period before each test did not contain fat. T h e last meal was always given 2 hr before the test. T h e diet in the 2 weeks preceding the tests contained about 25% of total calories at fat, mainly polyunsaturated, for all patients.
T h e intravenous fat tolerance test [2] was carried out according to the method of Carlson and Rossner [3] . For all tests, a 20% Intralipid emulsion [15] was administered intravenously in a dose of 0.1 g/kg body wt. Capillary blood samples were collected every 5 min. T h e Intralipid concentration was determined by nephelometry. For each disappearance curve a minimum of four consecutive points was used. T h e logarithms of the Intralipid concentrations were plotted against time. Straight lines were obtained from which the correlation coefficients were calculated.
T h e LPL activities were measured after the intravenous injection of 100 U heparinlkg body wt in 5-and
Results
Intralipid Elimination Constant in Patients and Control Subjects
The Intralipid elimination constants of the patients with a glucose 6-phosphatase deficiency and of the patients with a debranching enzyme deficiency were significantly lower than those of the control patients (P < 0.05). For the patients with a deficiency of the phosphorylase system, the difference was not significant (Tables I-V) .
Heparin-releaired L P L Activity in Patients and Control Subjects
T h e heparin-released LPL activity was higher in the 5-min sample than in the 40-min sample in the majority of GSD patients. Three out of six glucose 6-phosphatase-deficient patients, and one out of four debranching enzyme-deficient patients, however, showed 5-min activities lower than the 40-min activities. Most patients with a glucose 6-phosphatase deficiency showed lower 5-min LPL activities as compared with the control subjects, the difference between both groups being significant (P < 0.05). Some patients with a deficiency of debranching enzyme or a deficiency of the phosphorylase system showed decreased LPL activities as well, but the LPL activities of the latter two groups as a whole did not differ significantly from the LPL activities of the control subjects (Tables  I-V) . 2 The assay was modified and performed at a higher concentration of limit dextrin (normal range for leucocytes 2.07-5.04 (n = 8), for liver 2.13-9.09 (n = 3). 
Leuels of Triglyceride aind Cholesterol i n
Patients and Control Subjects 1). The Intralipid elimination constants and the
T h e triglyceride levels were significantly higher (P plasma trigl~cerides, On the One hand (Fig. 2) , and the < 0.05) in the three patient groups as with LPL activities 5 min after heparin injection and the the control subjects. The cholesterol values were sigplasma trigl~ceridesy On the hand (Fig. 3)9 were nificantly increased in the patients with a debranching not enzyme deficiency as compared with the control subjects (Tables I-V) . Discussion Much work has been done to find the cause of the Correlations of Intralipid Elimination Constants, L P L deficient LPL activity in disturbances of the triglycer~ctiuities, and Levels of Trigl~ceride i n ide elimination system. The synthesis of LPL activity of GSD Patients in adipose tissue taken from rats appears to be under
--
The Intralipid elimination constants and the LPL hormonal control. Insulin has a positive effect, activities 5 min after heparin injection showed a sigwhereas catecholamines, glucagon, growth-stimulating hormone, and adrenocorticotropic hormone have been shown to have a negative effect on the LPL activity [lo] . Further studies on the factors regulating LPL activity were described in 1966 by Salamon and Robinson [14] , who incubated intact epidymal fat bodies taken from rats that had been starved for 48 hr and in which the activity of LPL was low, in a medium designed to promote enzyme activity. They found that, as expected, the LPL activity increased to a level characteristic of the tissue of intact animals in the fed state. Glucose and insulin were important constituents of the incubation medium, insofar as the omission of either markedly reduced the increase in enzyme activity. Therefore, LPL synthesis in patients with a glucose 6-phosphatase deficiency may be impaired by the low levels of glucose and insulin in blood [6] . As for our patients with this enzyme defect, not only LPL activities, but also Intralipid clearance rates were significantly reduced as compared with the control patients. Our patients deficient in debranching enzyme or the phosphorylase system, however, in whom symptoms of hypoglycemia are mild and rare, showed LPL activities that did not differ significantly from those of the control patients. Nevertheless, the patients with a debranching enzyme deficiency showed Intralipid clearance rates significantly lower than the control subjects. We have no explanation for the discrepancy between the normal LPL activity and decreased fat elimination in debranching enzyme-deficient patients. Thus, we may explain the hyperlipidemia of GSD patients as follows. The hypertriglyceridemia of patients with a glucose 6-phosphatase deficiency is due to a combination of a decreased triglyceride elimination rate and increased endogenous liponeogenesis [7, 121, the former factor being the more important one. We did, indeed, observe that a high fat diet worsens the hypertriglyceridemia, which thus seems to be fat-induced (data not shown). The hyperlipidemia of patients with a deficiency of debranching enzyme or the phosphorylase system, however, is mainly caused by carbohydrate-induced liponeogenesis [4] , as impaired fat elimination probably plays a significant role in debranching enzyme deficiency only. (Discrepant results of fat elimination tests in debranching enzyme deficients do not permit a firm conclusion.) The dietary implications should be that for children deficient in glucose 6-phosphatase, a low fat, high carbohydrate diet is indicated, whereas for children with phosphorylase deficiency and possibly also those with a debranching enzyme deficiency, carbohydrate rather than fat restriction is indicated.
Summa y
T h e hyperlipidemia of 20 patients with GSD was studied by the intravenous Intralipid tolerance test and the determination of the plasma postheparin lipoprotein lipase activity. Patients with a glucose 6-phosphatase deficiency were characterized by abnormally low results for both tests as compared with control children. Patients with a deficiency of debranching enzyme showed a decreased Intralipid elimination constant, whereas the LPL activities did not significantly differ from control values. Patients with a deficiency of the phosphorylase system showed normal results for both tests.
